L
Laurence Collette
Researcher at European Organisation for Research and Treatment of Cancer
Publications - 281
Citations - 37642
Laurence Collette is an academic researcher from European Organisation for Research and Treatment of Cancer. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 78, co-authored 276 publications receiving 33811 citations. Previous affiliations of Laurence Collette include VU University Amsterdam & Université catholique de Louvain.
Papers
More filters
Journal ArticleDOI
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.
M. J. van den Bent,D Afra,O De Witte,M Ben Hassel,S. Schraub,Khê Hoang-Xuan,Per-Uno Malmström,Laurence Collette,Marianne Pierart,René-Olivier Mirimanoff,Abmf Karim +10 more
TL;DR: Early radiotherapy after surgery lengthens the period without progression but does not affect overall survival, and Radiotherapy could be deferred for patients with low-grade glioma who are in a good condition, provided they are carefully monitored.
Journal ArticleDOI
Duration of androgen suppression in the treatment of prostate cancer.
Michel Bolla,Theodorus M. de Reijke,Geertjan van Tienhoven,Alphonsus C.M. van den Bergh,Jorg R. Oddens,Philip Poortmans,Eliahu Gez,Paul Kil,Atif Akdas,Guy Soete,Oleg B. Kariakine,Elsbietha M. van der Steen-Banasik,Elena Musat,Marianne Pierart,Murielle Mauer,Laurence Collette +15 more
TL;DR: The combination of radiotherapy plus 6 months of androgen suppression provides inferior survival as compared with radiotherapyplus 3 years of androgens suppression in the treatment of locally advanced prostate cancer.
Journal ArticleDOI
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
Michel Bolla,Geertjan van Tienhoven,Padraig Warde,Jean Bernard Dubois,René-Olivier Mirimanoff,Guy Storme,Jacques Bernier,Abraham Kuten,Cora N. Sternberg,Ignace Billiet,José Lopez Torecilla,Raphael Pfeffer,Carmel Lino Cutajar,Theodore H. van der Kwast,Laurence Collette +14 more
TL;DR: In patients with prostate cancer with high metastatic risk, immediate androgen suppression with an LHRH agonist given during and for 3 years after external irradiation improves 10-year disease-free and overall survival without increasing late cardiovascular toxicity.
Journal ArticleDOI
Internal mammary and medial supraclavicular irradiation in breast cancer
P. Poortmans,Sandra Collette,C. Kirkove,E. Van Limbergen,Volker Budach,H. Struikmans,Laurence Collette,A. Fourquet,Philippe Maingon,M.C. Valli,K. De Winter,Simone Marnitz,Isabelle Barillot,L. Scandolaro,Ernest Vonk,Carla C. Rodenhuis,Hugo Marsiglia,N. Weidner,G. van Tienhoven,C. Glanzmann,Abraham Kuten,Rodrigo Arriagada,Harry Bartelink,W. Van den Bogaert +23 more
TL;DR: In patients with early-stage breast cancer, irradiation of the regional nodes had a marginal effect on overall survival, disease-free survival and distant disease- free survival were improved, and breast-cancer mortality was reduced.
Journal ArticleDOI
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
Michel Bolla,Hein Van Poppel,Bertrand Tombal,K. Vekemans,Luigi F. Da Pozzo,Theo M. de Reijke,Antony Verbaeys,Jean-François Bosset,Roland Van Velthoven,Marc Colombel,Cees van de Beek,Paul C.M.S. Verhagen,Alphonsus C.M. van den Bergh,Cora N. Sternberg,Thomas C. Gasser,Geertjan van Tienhoven,Pierre Scalliet,Karin Haustermans,Laurence Collette +18 more
TL;DR: Results at median follow-up of 10·6 years show that conventional postoperative irradiation significantly improves biochemical progression-free survival and local control compared with a wait-and-see policy, supporting results at 5 year follow- up; however, improvements in clinical progression- free survival were not maintained.